Federal Supply Schedule 36F79722D0107

Award Date 4/15/22
Last Date to Order 3/14/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 12 awarded Stratus Pharmaceuticals Inc., a minority-owned, woman-owned small business, a multiple-award Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products. The contract has a potential value of $14,425,700 over the period from October 1, 2023 through September 30, 2028. This FSS contract allows federal agencies to place...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract was awarded to Haleon US LP, a for-profit manufacturer, with a ceiling value of $9,867,650.00 and a period of performance through September 30, 2026. The FSS contract, categorized under Schedule 65 IB, aims to provide the VA's VISN 12 with a wide...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
The key products and services being delivered under this Federal Supply Schedule (FSS) contract IDV award include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Mallinckrodt Hospital Products Inc., is a foreign-owned, for-profit entity registered to receive federal government awards. This $140,039,590 multiple award FSS contract was issued by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract...
The Federal Supply Schedule (FSS) contract awarded to Sterisyn Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) provides a wide range of pharmaceutical and hematology-related products to support VA healthcare programs for veterans. Valued at up to $50,775,470 through May 2029, this multiple-award IDV contract allows the VA and other federal agencies to order pharmaceuticals such as gabapentin, TYVASO, and naproxen through firm fixed price delivery orders. As a...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
The Federal Supply Schedule (FSS) Contract No. V797D70214 was awarded by the Department of Veterans Affairs (VA) to STI Pharma LLC, a for-profit limited liability company manufacturer of goods. The contract is under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, with a ceiling value of $225,000.00 and a period of performance through May 14, 2026. The contract aims to procure a range of pharmaceutical and hematology-related products for the VA, which is a civilian agency. No...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...
The Federal Supply Schedule contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 provides pharmaceuticals and related hematology products. Specifically, the multiple award contract supports Schedule 65 IB for drugs, pharmaceuticals, and associated goods. With a potential value of $7,750,000 and a period of performance through September 2028, Toprail CHP LLC will supply various pharmaceutical items to medical facilities...

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Federal Supply Schedule (FSS) contract to Stratatech Corporation, a subsidiary of Mallinckrodt Plc, for pharmaceutical, drug, and hematology-related products. The multiple-award FSS contract is under Schedule 65 IB and has a potential value of $850,000 with a period of performance through March 2027.

Under this contract, Stratatech Corporation provides a range of pharmaceutical treatments, medications for chronic diseases, hematology products, and other drug-based therapies to support healthcare services for veterans across the VA's Network 12 region. An earlier interim agreement under the same schedule provided $25,000 for similar pharmaceutical procurement within Network 12 from November 2021 to April 2022. This Federal Supply Schedule contract allows the VA to efficiently procure a variety of pharmaceutical and related medical products from Stratatech Corporation to meet the healthcare needs of the veteran population served by Network 12.

Generated 5/4/24, 9:04 AM